Pharmacy teams can prevent early discontinuation by setting clear expectations for when—and how—a medication's benefit will become apparent.
|Articles|June 29, 2023
- June 2023
- Volume 89
- Issue 6
June 2023 Pet Peeves
Advertisement
Co-Pay Conniption
Patients who say, “I have NEVER had to pay a co-pay before.”
Articles in this issue
over 3 years ago
June 2023 Interactive Case Studiesover 3 years ago
June 2023 OTC Product Newsover 3 years ago
COVID-19 OTC Case Studiesover 3 years ago
Keep Seasonal Allergy Symptoms in Checkover 3 years ago
Deprescribing, Medication Therapy Management Go Hand in Handover 3 years ago
Pharmacist Challenges Revocation of License to Practiceover 3 years ago
“I Want Everyone to Walk in and Say, ‘Wow!’ "over 3 years ago
AI Plus Mobile App May Help With Smoking CessationAdvertisement
Related to this article
Pharmacists make a difference in patients’ lives through MTM services.
Peptide cancer vaccines target neoantigens to boost T cells, with promising melanoma and pancreatic trials hinting at a new era in immunotherapy.
AI tools in pharmacy education risk eroding critical thinking, lab competency, and patient safety if used as substitutes for foundational learning.
Each October, the pharmacy profession pauses to recognize technicians' decades-long evolution, from on-the-job trainees to nationally certified health care professionals.
Peer Reviewed
Creating institution-specific, literacy-friendly chemotherapy education sheets resulted in patient education materials with higher readability scores than similar materials from common chemotherapy education sites.
In an era of rapidly evolving technology, we remain in a people-powered world.
How oncology pharmacy leaders fight burnout with stay surveys, smarter schedules, and recognition—building resilient teams through loss and turnover.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Finerenone Expands MRA Options as Pharmacists Address Underrecognized HFpEF
2
Diuretics, eGFR, and Intensive BP Lowering in CKD: What to Watch
3
Researchers Target Viral Fusion for Universal Flu, HIV Vaccines
4
Finerenone in Heart Failure: Evidence and Practice a Year Later
5